PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 8 months ago Dermapharm Holding SE increases revenue as projected and exceeds guidance for adjusted consolidated EBITDA Dermapharm Holding SE reports 4.0% increase in consolidated revenue to EUR 1,180.8 million for 2024 with adjusted EBITDA rising by 1.7% to EUR 315.6 million. Strong growth in branded pharmaceuticals segment Financial Results Adjusted EBITDA Consolidated Revenue Dermapharm Holding SE Branded Pharmaceuticals
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 8 months ago Steyr Motors confirms successful global business development strategy with further framework agreement from Brazil – Order backlog increases to almost EUR 200 million by 2027 Steyr Motors AG confirms successful global business development strategy with a new framework agreement from Brazil, increasing order backlog to nearly EUR 200 million by 2027 Growth Strategy Order Backlog Framework Agreement Global Business Steyr Motors AG
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 8 months ago Former DAX-CEO Kasper Rørsted joins AI-Robotics Company Circus SE Former DAX-CEO Kasper Rørsted joins AI-Robotics Company Circus SE to support global scale-up of Embodied AI robot for food service industry. Strategic expertise to redefine food production through robotics and AI Circus SE Food Production AI-Robotics Kasper Rørsted Embody AI
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 8 months ago Lenzing Group continued its recovery course in the 2024 financial year Lenzing Group's 2024 financial year shows revenue growth of 5.7% to EUR 2.66 bn, with EBITDA up 30.4% and free cash flow positive. CEO anticipates market challenges in 2025 EBITDA Revenue Growth Market Challenges 2024 Financial Year Lenzing Group
PRESS RELEASE published on 03/14/2025 at 07:30, 1 year 8 months ago Inside Information / News release on accounts, results Sensorion reports full-year 2024 results and provides corporate update with significant milestones achieved in gene therapy clinical trials and financial highlights. Company well positioned for growth in 2025 Clinical Trials Financial Highlights Gene Therapy Full-year Results Sensorion
PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 8 months ago Swiss Life in 2024: fee result up 33% and net profit up 13% – “Swiss Life 2024” Group-wide programme successfully concluded Swiss Life reports strong financial results for 2024, with fee result up 33% and net profit up 13%. Successful conclusion of 'Swiss Life 2024' programme Financial Results Dividend 2024 Swiss Life Swiss Life 2024
PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 8 months ago Implenia wins major rail project in Sweden Implenia awarded CHF 130 million contract by Swedish Transport Administration for 'East Link' railway project, enhancing travel in eastern Sweden. Project includes bridges, railway tracks, and refurbishment, scheduled for completion in 2031 Sweden Implenia Railway Project East Link Swedish Transport Administration
PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 8 months ago BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS BioVersys AG announces reporting date for full-year 2024 financial results and event details, including a conference call and webcast on March 26, 2025. The company focuses on developing novel antibacterial products for MDR bacteria Financial Results Conference Call BioVersys AG Antibacterial Products MDR Bacteria
REGULATED PRESS RELEASE published on 03/14/2025 at 07:00, 1 year 8 months ago Coach and Interparfums extend their partnership in the universe of fragrances until June 2031 Coach and Interparfums extend their fragrance partnership until June 2031, renewing the license and launching new products for brand development Interparfums Brand Development Coach Fragrance Partnership License Renewal
PRESS RELEASE published on 03/14/2025 at 06:59, 1 year 8 months ago Matador Secondary Private Equity AG: Matador generated a profit of CHF 6.3 million in the 2024 financial year and the net asset value increased by almost 12% Matador Secondary Private Equity AG reported a profit of CHF 6.3 million and a 12% increase in net asset value for the 2024 financial year. The company shows confidence in future successful financial performance Private Equity Net Asset Value Profit 2024 Financial Year Matador Secondary Private Equity AG
Published on 11/16/2026 at 11:00, 1 hour 58 minutes ago Golden Minerals Reports Third Quarter 2026 Financial Results
Published on 11/16/2026 at 11:00, 1 hour 58 minutes ago Strategic Metals Reports Promising Results From the Rusty and Ranch Projects
Published on 11/16/2026 at 09:10, 3 hours 48 minutes ago OBI Pharma Signs Collaboration and License Agreement with Novartis
Published on 11/16/2026 at 08:00, 4 hours 58 minutes ago Namibia Securities Exchange Listing and Commencement of Trading
Published on 11/16/2026 at 00:00, 12 hours 58 minutes ago Redwood AI Plans to Develop Canadian and U.S. Defence Compliance Capabilities for its Post-Quantum Cybersecurity Platform
Published on 11/16/2026 at 12:13, 44 minutes ago Guillemot Corporation S.A. | Weekly report share buyback from November 9 to November 13, 2026
Published on 11/13/2026 at 11:35, 3 days 1 hour ago ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Published on 11/12/2026 at 23:12, 3 days 13 hours ago Belgrano continues the implementation of its public share buyback offer (OPRA)
Published on 11/12/2026 at 18:36, 3 days 18 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/10/2026
Published on 11/12/2026 at 18:00, 3 days 18 hours ago Information concerning the total number of voting rights and shares in the share capital as of November 12, 2026